side effects Tagged Articles

Could ‘Low T’ treatments be dangerous to your health?

Posted: April 23, 2014 Pharmaceutical

If you’re a man and you listen to the advertisements from some drug makers describing a condition known as “Low T” with symptoms such as low libido, zapped energy levels, weight gain and muscle loss, you might be tempted to

Alabama residents with Type 2 diabetes sought for long-term study on medication effectiveness

Posted: April 22, 2014 Pharmaceutical

Researchers at the University of Alabama at Birmingham (UAB) are enrolling participants in an ongoing study on the long-term benefits and side effects with certain combinations of drugs to treat type 2 diabetes.

Vials of injectable sleep drug Propofol recalled

Posted: April 22, 2014 Recalls

Hospira is recalling seven lots of Propofol Injectable Emulsion, an anesthetic used to put people to sleep before and during surgeries, due to visible metal particles floating in glass vials of the solution.

Participants sought to test long-term effects of popular type 2 diabetes drugs

Posted: April 21, 2014 Pharmaceutical

Researchers at Washington University School of Medicine in St. Louis are seeking volunteers to participate in a study comparing the long-term risks and benefits of four widely prescribed diabetes drugs. The medications will be given in combination with the widely

FDA approves new type 2 diabetes drug Tanzeum

Posted: April 18, 2014 Pharmaceutical

After a three-month delay, the Food and Drug Administration (FDA) has approved GlaxoSmithKline’s new type 2 diabetes treatment, albiglutide. The drug will be marketed in the United States as Tanzeum.

Cases of diabetes on the rise in the United States

Posted: April 17, 2014 Pharmaceutical

The number of Americans with diabetes has nearly doubled in the past 20 years, paralleling the country’s growing obesity epidemic. Experts say if the trend continues, the number of Americans with diabetes will reach 44 million in the next 20

FDA delays decision on diabetes inhaler to review possible cancer risks

Posted: April 11, 2014 Pharmaceutical

The Food and Drug Administration (FDA) has delayed its decision about whether to approve Mannkind Corp.’s Afrezza, an inhaled insulin treatment for diabetes, due to concerns about an increased risk of lung cancer.

Zohydro maker files lawsuit to block Massachusetts governor’s ban

Posted: April 10, 2014 Pharmaceutical

Less than a week after Massachusetts governor Deval Patrick banned the sale of the controversial new potent painkiller Zohydro, the drug’s maker has filed a lawsuit aimed at blocking the governor’s request.

EPA human test subjects were not always told of cancer, death risks

Posted: April 8, 2014 Personal Injury

The Environmental Protection Agency (EPA) is being strongly encouraged to overhaul its guidelines for human test subjects after an investigation found that many of the people signed up to test the impact of pollutants for the agency were not always

Dramatic increase in poison center calls regarding e-cigarettes encourages stronger government oversight

Posted: April 7, 2014 Personal Injury

The number of calls to poison centers regarding e-cigarette liquids containing nicotine has increased dramatically in recent years from just one a month in 2010 to 215 a month so far in 2014, according to the Centers for Disease Control